News

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
California Trim Rx has been providing a local, community-based experience for residents in Encinitas and the surrounding ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...